Dried flower 18 percent: where this range overlaps with the declaration of 20 percent

What exactly does the declared percentage on the dried flower label mean?

The percentage on the packaging is the manufacturer's declaration, not the measurement result of that specific batch. The declaration carries a tolerance of ten percent in either direction, so the eighteen describes material from 16.2 to 19.8 percent. Some registered items print these limits directly, while others provide only the nominal value. Nothing in this number indicates the strength of the effect.

The number refers to delta-9-tetrahydrocannabinol in its neutral form. In raw flower, the acidic form predominates, which the laboratory converts to this form, and the difference between the declaration and the measurement, as well as the calculation from the acidic form, is elaborated. a page dedicated to the twenty percent declaration.

The tolerance is a record of what is allowed, not a forecast of what has been measured. An item with a 20 percent declaration may be described in the composition with a statement of a content not less than 18 and not more than 22 percent, and in pharmacy listings, it often appears with just the twenty. The reader then sees one number where the document presents a range.

Finally, a distinction that is easy to overlook. Dried flower sold over the counter in the category of dried flower has a tetrahydrocannabinol content below the legal threshold and is not the same product as the raw material from the pharmacy. This page describes only the latter and is not a list of packages; it maintains the state of trade. a summary of available strains.

Why do the ranges for 18 and 20 percent overlap?

Because the tolerance is calculated from the nominal value, not from the boundary of the neighboring declaration. The eighteen stretches from 16.2 to 19.8 percent, while the twenty ranges from 18.0 to 22.0. The segment from 18.0 to 19.8 belongs to both, so one measured value fits into two different labels.

The calculation involves four multiplications. The lower limit of the eighteen is 18 times 0.9, which equals 16.2 percent, and the upper limit is 18 times 1.1, which equals 19.8 percent. For the twenty, it comes out to 20 times 0.9, which is 18.0 percent, and 20 times 1.1, which is 22.0 percent. The common part begins where the lower limit of the stronger declaration meets the upper limit of the weaker one, and has a width of 1.8 percentage points.

Practically, this means that a batch described as weaker and a batch described as stronger can show the same number on the label, for example, 19.0 percent, while both remain compliant with their label. Neither is then described incorrectly. Furthermore: a batch from the eighteen measured at the upper end has 19.8 percent, and a batch from the twenty measured at the lower end has 18.0 percent, so the weaker label can sometimes be the stronger material.

What this calculation does not say: how often this occurs. The range describes what is permissible, not the distribution of measurement results in subsequent batches. Publicly available listings do not provide results for individual batches, so the percentage of batches landing in the common part remains unknown. However, in the summary of strains from this cluster, traces of this phenomenon are visible: 26 out of 85 cultivars have a position with an eighteen percent declaration, and 16 of them are also listed in a stronger position.

How high does this common part reach on the ladder of declarations?

Higher than would be inferred from the gap between the labels. Two declarations have a common part when the higher one is at most 1.222 times greater than the lower one. At this threshold, the eighteen overlaps with the twenty, touching the twenty-two exactly at one point, while the twenty-five overlaps with the thirty.

The threshold is taken directly from the definition of tolerance. The upper limit of the weaker declaration is 1.1 times its nominal value, and the lower limit of the stronger one is 0.9 times its value, so the ranges have a common point as long as the ratio of both declarations does not exceed eleven ninths, or about 1.222.

The same rule explains why the common part does not disappear as the gap increases. The width of the range is two tenths of the declaration, and thus it grows along with it: 3.6 percentage points for the eighteen compared to 6.0 points for the thirty. Therefore, the twenty-five and thirty, although separated by five declaration points, have a common segment from 27.0 to 27.5 percent, while the twenty-two and twenty-seven diverge by 0.1 points.

The eighteen percent mark has a special place here. Its upper limit, 19.8 percent, is also the lower limit of the twenty-two percent mark, because 22 is exactly eleven ninths of eighteen. Therefore, these two declarations do not overlap but touch at one point: the single value of 19.8 percent fits into both. Below are the limits of six declarations spotykanych w polskich pozycjach rejestrowych.

How is the strength of the raw material matched to the patient?

This is determined by the attending physician, as this raw material is dispensed from the pharmacy only with a prescription in the Rpw category. The selection process is gradual, starting from small doses towards one that provides the desired effect, and the declared percentage is just one of the parameters of this process, alongside the method of administration and frequency.

The selection itself is called titration and is developed separately. strona o deklaracji dwudziestodwuprocentowej, along with the question of the patient's variable tolerance over time. Here, one note arises from the calculation above: since the ranges of neighboring declarations have a common part, transitioning from the eighteen percent position to the twenty percent position does not necessarily mean a material stronger by two points, and sometimes it does not indicate a stronger material at all.

The second reason why the label does not directly translate to the dose lies beyond the raw material itself. The percentage describes the mass fraction in the dried flower, not how much substance will enter the body, as this is determined by the route of administration and the efficiency of the device. Two people using the same batch receive different amounts.

Therefore, the page with numbers does not replace a conversation in the office. The comparison of limits shows what is permissible for the manufacturer, and nothing more: it does not say how much substance reaches the patient or what dose is appropriate for them. That remains the decision of the attending physician, made with a complete list of medications taken in mind.

Does the declared percentage change the onset of action and its duration?

No. The course over time is determined by the route of administration, not the number on the package. A higher declaration only indicates that the same mass of dried flower carries more active substance, so it is arithmetic of content, not a description of when the effect appears and how long it lasts.

The route of administration determines the course more than the variety itself. After vaporization, the substance passes from the lungs to the blood almost immediately, so the first sensations appear after a few minutes, the intensity increases for another ten to thirty minutes, and the whole effect lasts for two to four hours. After ingestion, the raw material first passes through the intestine and liver, so the first sensations are awaited from half an hour to two hours, and the episode can last six, sometimes eight hours. Hence the most common mistake with oral administration: anyone who thinks nothing is happening after thirty minutes and takes another dose will receive both doses at once. The above ranges describe the route of administration, not this variety; pharmacokinetic studies for a single cultivar have not been published.

For a pair of declarations from this page, the difference is smaller than it appears on the label. If a batch described as eighteen percent measures 19.0 percent, and a batch described as twenty percent measures the same, then both carry an identical amount of substance in the same mass of raw material, and nothing in their course can differ due to the label. The number changes by two points, but the material does not change at all.

What is known, and what is not known about the relationship between the potency of the raw material and the effect?

It is known that higher concentrations are associated with poorer outcomes in non-medical use, mainly in terms of psychosis and addiction. However, it is not known whether they provide more effective treatment: there are few medical studies, their results vary widely, and the certainty of evidence has been rated by review authors as very low.

The evidence is asymmetrical. The largest review gathered 99 studies with a total of 221,097 participants, of which randomization was conducted in 42 percent. In studies that did not evaluate medical use, high concentrations were associated with psychosis or schizophrenia in seventy percent, and with addiction in seventy-five. Moderate or high risk of systematic error burdened over 95 percent of included items (PMID:40854216).

On the medical side, the same review shows divergence, not a result. For anxiety, benefits were reported in 47 percent of studies, for depression 48, but the same sets of studies also yielded contrary signals, respectively in 24 and 30 percent. An older review, 20 observational studies selected from 4,171 screened articles, linked greater potency with increased risk of psychosis and addiction, while for depression and anxiety, it considered the evidence inconsistent, lacking a single measure of exposure (PMID:35901795).

A newer review, based on 42 studies selected from 4545 records, divided potency into categories corresponding to the market, and assessed the overall certainty of evidence as very low (PMID:40134269); the same categories are elaborated on the page about the twenty-five percent declaration. The fourth position is a meta-analysis showing that the raw material studied in earlier years was weaker than that currently in circulation (PMID:33160291); this topic is addressed on the page about the thirty percent mark.

For this page, one limitation common to all four studies is important: none examines a single declaration. The categories used in these reviews have ten percentage points or more, and their boundaries cut across label ranges. The eighteen reaches up to 19.8 percent, thus going beyond the category from 10 to 19; the twenty, from 18.0 to 22.0 percent, lies at the lower end of this category, and at the upper end already in the next one. Therefore, the separation of eighteen from twenty lies below the resolution of the evidence that exists.

What adverse effects are associated with higher potency raw material?

The same as with lower potency dried flower, except that reviews link higher concentrations to a more frequent occurrence of psychosis and dependence in non-medical use. For the difference between the declaration of eighteen and twenty percent, there are no separate data, as reports are not divided that finely.

Reports of adverse effects are collected for medicinal products with a batch number, not for the strain name, so the following pertains to hemp dried flower as a group of raw materials. The most frequently reported symptoms are dry mouth, red eyes, and increased heart rate. Dizziness upon rapid standing, daytime drowsiness, and temporary worsening of short-term memory are less frequently described, as well as anxiety that increases with dosage. A separate issue is medications taken concurrently, especially sedatives and those affecting coagulation: their assessment requires knowledge of the entire list of preparations, not just the description of the plant. We do not provide the frequency of these symptoms numerically, as public compilations for hemp dried flower in Poland do not separate them by individual products.

The potency of the raw material adds to this list only as much as is visible in observational study reviews: more frequent reports of psychosis and cannabis dependence with products of higher concentration, with the studies being non-randomized and lacking a uniform exposure measure. The adverse effects themselves, along with what is known about their frequency, rozwija strona o deklaracji dwudziestosiedmioprocentowej.

Frequently Asked Questions

Can dried flower labeled 18 percent be stronger than dried flower labeled 20 percent?

Yes, and this is due to the arithmetic of tolerance. The upper limit of the eighteen percent declaration is 19.8 percent, while the lower limit of the twenty percent declaration is 18.0 percent, so a batch from the first can contain more substances than a batch from the second, both in accordance with the label.

Does a higher declared percentage mean stronger or better therapeutic action?

It has not been shown that a higher declared percentage on the label indicates stronger or better therapeutic effects. The evidence regarding the potency of the raw material pertains almost exclusively to adverse effects and non-medical use, not efficacy, and studies on therapeutic applications are few and yield mixed results. The authors of both of the latest reviews assessed the certainty of evidence as very low. There is also no study that compared two pharmaceutical dried flowers differing only in declared content.

What is the range for the 18 percent declaration?

From 16.2 to 19.8 percent. The lower limit is 18 multiplied by 0.9, the upper limit is 18 multiplied by 1.1, which means a tolerance of ten percent of the nominal value in both directions. The entire range has a width of 3.6 percentage points.

Does the range mean that the measurement usually lies at its end?

No. The limits indicate what can be marketed under a given label, not how the results of measurements of subsequent batches are distributed. Public records do not provide these results, so the frequency of hitting the common segment with the neighboring declaration remains unknown.

Does changing the position from 18 percent to 20 percent mean a stronger material?

Not necessarily. The ranges of both declarations have a common segment from 18.0 to 19.8 percent, so a two-point difference on the packaging does not have to correspond to any difference in content. Whether such a change makes sense is determined by the attending physician, not by tolerance calculations.

Where can I check which products with an 18 percent declaration are currently available?

W in the list of available medical marijuana strains, which is updated separately and shows the state of circulation. This page is not a list of packages: it explains what the number on the label means, not which packages are currently available in pharmacies.

Hemp flower is a pharmaceutical raw material dispensed by a doctor's prescription in the Rpw category. The material is for informational purposes only and does not replace medical advice or the decisions of the attending physician. Editorial text: redakcja ubucha.pl.